Your browser doesn't support javascript.
loading
Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases.
Shah, Neal; Mohammad, Afroz S; Saralkar, Pushkar; Sprowls, Samuel A; Vickers, Schuyler D; John, Devin; Tallman, Rachel M; Lucke-Wold, Brandon P; Jarrell, Katherine E; Pinti, Mark; Nolan, Richard L; Lockman, Paul R.
Afiliação
  • Shah N; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: nlshah@mix.wvu.edu.
  • Mohammad AS; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: asmohammad@mix.wvu.edu.
  • Saralkar P; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: pas0020@mix.wvu.edu.
  • Sprowls SA; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: sas0040@mix.wvu.edu.
  • Vickers SD; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: sdv0006@mix.wvu.edu.
  • John D; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: dujohn@mix.wvu.edu.
  • Tallman RM; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: rmtallman@mix.wvu.edu.
  • Lucke-Wold BP; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: bwold@mix.wvu.edu.
  • Jarrell KE; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: kejarrell@mix.wvu.edu.
  • Pinti M; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: mpinti@mix.wvu.edu.
  • Nolan RL; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: rlnolan@mix.wvu.edu.
  • Lockman PR; West Virginia University, Health Sciences Center, School of Pharmacy, Department of Basic Pharmaceutical Sciences, Morgantown, WV 26506, USA. Electronic address: prlockman@hsc.wvu.edu.
Pharmacol Res ; 132: 47-68, 2018 06.
Article em En | MEDLINE | ID: mdl-29604436
Assuntos
Palavras-chave
5-Azacitidine (PubMED CID: 9444); 5-Fluorouracil (PubMED CID: 3385); Abemaciclib (PubMED CID: 46220502); Afatinib (PubMED CID: 10184653); Alisertib (PubMED CID: 24471867); Alpelisib (PubMED CID: 56649450); Anastrozole (PubMED CID: 2187); Apitolisib (PubMED CID: 25254071); Bleomycin (PubMED CID: 5360373); Breast cancer brain metastases; Brilanestrant (PubMED CID: 56941241); Buparlisib (PubMED CID: 16654980); Cabozantinib (PubMED CID: 25102847); Capecitabine (PubMED CID: 60953); Carmustine (PubMED CID: 2578); Cisplatin (PubMED CID: 84691); Clinical trials; Cyclophosphamide (PubMED CID: 2907); Cytarabine (PubMED CID: 6253); Dactolisib (PubMED CID: 11977753); Daunorubicin (PubMED CID: 30323); Docetaxel (PubMED CID: 148124); Doxorubicin (PubMED CID: 31703); Elacestrant (PubMED CID: 23462301); Entinostat (PubMED CID: 4261); Eribulin (PubMED CID: 17755248); Estradiol (PubMED CID: 5757); Etirinotecan pegol (PubMED CID: 71300725); Etoposide (PubMED CID: 36462); Everolimus (PubMED CID: 18477728); Exemestane (PubMED CID: 60198); Fulvestrant (PubMED CID: 104741); Gemcitabine (PubMED CID: 60750); Goserelin (PubMED CID: 5311128); Ifosfamide (PubMED CID: 3690); Iniparib (PubMED CID: 9796068); Irinotecan (PubMED CID: 60838); Lapatinib (PubMED CID: 208908); Lenvatinib (PubMED CID: 9823820); Letrozole (PubMED CID: 3902); Leuprorelin (PubMED CID: 657181); Liposomes; Lomustine (PubMED CID: 3950); Methotrexate (PubMED CID: 126941); Mitoxantrone (PubMED CID: 4212); Nanoparticles; Neratinib (PubMED CID: 9915743); Novel chemotherapy; Olaparib (PubMED CID: 23725625); Paclitaxel (PubMED CID: 36314); Palbociclib (PubMED CID: 122706004); Pegylation; Pictilisib (PubMED CID: 17755052); Pilaralisib (PubMED CID: 56599306); Ribociclib (PubMED CID: 44631912); Rucaparib (PubMED CID: 9931954); Sonidegib (PubMED CID: 24775005); Sunitinib (PubMED CID: 5329102); Tamoxifen (PubMED CID: 2733526); Taselisib (PubMED CID: 51001932); Temozolomide (PubMED CID: 5394); Teniposide (PubMED CID: 452548); Topotecan (PubMED CID: 60700); Tucatinib (PubMED CID: 51039094); Veliparib (PubMED CID: 11960529); Vincristine (PubMED CID: 5978); Vinorelbine (PubMED CID: 5311497); Voxtalisib (PubMED CID: 49867926); Z-Endoxifen (PubMED CID: 10090750)
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias da Mama / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Neoplasias da Mama / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article